Business Context and Reporting Period
This Form 8-K Current Report was filed by Anavex Life Sciences Corp. on March 4, 2022. The report discloses significant corporate governance changes, specifically the dismissal of the company's independent registered public accounting firm and the engagement of a new firm, as well as an amendment to the employment agreement of the Principal Financial Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on non-financial corporate events.
Material Changes
- Change in Auditor: On March 1, 2022, the Audit Committee dismissed BDO USA LLP as the independent registered public accounting firm. The dismissal was not due to any disagreements on accounting principles, practices, or audit scope during the fiscal years ended September 30, 2021 and 2020, or the interim period through March 1, 2022.
- New Auditor Engagement: On March 3, 2022, the Audit Committee engaged Grant Thornton LLP as the new independent registered public accounting firm for the fiscal year ending September 30, 2022. No consultations regarding accounting principles or audit opinions occurred with Grant Thornton prior to this engagement.
- Executive Compensation: On February 28, 2022, the company amended the employment agreement with its Principal Financial Officer (Sandra Boenisch), effective March 1, 2022. The amendment sets the annual base salary at $240,000 Canadian dollars.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, future outlook, or management commentary on business strategy. The primary risk disclosed relates to the change in auditors, though the company explicitly stated there were no reportable events or disagreements with the former auditor. The press release regarding the auditor change is included as an exhibit but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the reasons for the auditor change by reviewing the letter from BDO USA LLP (Exhibit 16.1) to confirm no undisclosed disagreements exist.
- Confirm the transition timeline and scope of work for the new auditor, Grant Thornton LLP, for the fiscal year ending September 30, 2022.
- Review the full text of Amendment No. 2 to the Principal Financial Officer's employment agreement (Exhibit 10.1) for details on equity compensation or other terms beyond the base salary.
- Check subsequent filings (e.g., 10-K or 10-Q) for the first financial statements audited by Grant Thornton LLP.